Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes.
Diabetes care; 2007 Jun;30(6):1608-10. PMID: 17372153
Department of Internal Medicine, Gentofte Hospital, Hellerup, Denmark. t.vilsboll@dadlnet.dk
Category: